 Christine Vohwinkel
Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Lung Injury | 7 | 2023 | 268 | 3.140 |
Why?
| | Pneumonia | 2 | 2022 | 563 | 1.080 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-2 | 3 | 2017 | 6 | 0.830 |
Why?
| | Lung | 9 | 2023 | 3521 | 0.740 |
Why?
| | Succinate Dehydrogenase | 1 | 2021 | 42 | 0.730 |
Why?
| | Macrophages, Alveolar | 1 | 2023 | 348 | 0.710 |
Why?
| | Glycogen Synthase Kinase 3 beta | 2 | 2017 | 60 | 0.700 |
Why?
| | Pulmonary Alveoli | 3 | 2021 | 372 | 0.690 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2022 | 250 | 0.570 |
Why?
| | ELAV-Like Protein 1 | 1 | 2017 | 15 | 0.550 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2021 | 333 | 0.540 |
Why?
| | RNA Stability | 1 | 2017 | 90 | 0.520 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2016 | 29 | 0.510 |
Why?
| | Hypercapnia | 2 | 2013 | 50 | 0.480 |
Why?
| | Ion Channels | 2 | 2013 | 121 | 0.460 |
Why?
| | Viral Matrix Proteins | 1 | 2013 | 24 | 0.430 |
Why?
| | Phosphofructokinase-2 | 2 | 2022 | 14 | 0.400 |
Why?
| | Disease Models, Animal | 3 | 2018 | 3498 | 0.400 |
Why?
| | Animals | 17 | 2023 | 31567 | 0.370 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2013 | 287 | 0.340 |
Why?
| | Carbon Dioxide | 1 | 2011 | 218 | 0.340 |
Why?
| | Hypoxia | 2 | 2016 | 956 | 0.340 |
Why?
| | RNA, Messenger | 1 | 2017 | 2550 | 0.330 |
Why?
| | Inflammation | 4 | 2023 | 2464 | 0.320 |
Why?
| | Alveolar Epithelial Cells | 2 | 2023 | 93 | 0.310 |
Why?
| | Up-Regulation | 1 | 2011 | 802 | 0.300 |
Why?
| | Mice | 9 | 2023 | 14845 | 0.300 |
Why?
| | MicroRNAs | 3 | 2022 | 600 | 0.290 |
Why?
| | Lipopolysaccharides | 2 | 2023 | 813 | 0.290 |
Why?
| | Hydrochloric Acid | 2 | 2018 | 8 | 0.290 |
Why?
| | Ventilator-Induced Lung Injury | 2 | 2018 | 49 | 0.260 |
Why?
| | Mitochondria | 1 | 2011 | 744 | 0.260 |
Why?
| | Postoperative Complications | 1 | 2016 | 2122 | 0.250 |
Why?
| | Transforming Growth Factor beta | 2 | 2017 | 445 | 0.240 |
Why?
| | Cell Proliferation | 1 | 2011 | 2173 | 0.230 |
Why?
| | Signal Transduction | 2 | 2021 | 4501 | 0.220 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2023 | 14 | 0.210 |
Why?
| | Humans | 21 | 2023 | 114050 | 0.200 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4681 | 0.200 |
Why?
| | Period Circadian Proteins | 1 | 2022 | 12 | 0.200 |
Why?
| | Lactic Acid | 1 | 2023 | 272 | 0.200 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2021 | 20 | 0.190 |
Why?
| | Acid-Base Equilibrium | 1 | 2021 | 29 | 0.180 |
Why?
| | Endocytosis | 3 | 2017 | 146 | 0.180 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 192 | 0.180 |
Why?
| | Anti-Inflammatory Agents | 1 | 2023 | 445 | 0.170 |
Why?
| | Acidosis | 1 | 2021 | 86 | 0.170 |
Why?
| | Endothelial Cells | 2 | 2021 | 677 | 0.160 |
Why?
| | Coronary Vessels | 1 | 2021 | 234 | 0.160 |
Why?
| | Receptor, EphA2 | 1 | 2018 | 19 | 0.150 |
Why?
| | Pulmonary Edema | 1 | 2017 | 109 | 0.140 |
Why?
| | A549 Cells | 1 | 2017 | 51 | 0.140 |
Why?
| | Heart Ventricles | 1 | 2021 | 723 | 0.130 |
Why?
| | Cytokines | 1 | 2023 | 1824 | 0.130 |
Why?
| | Mice, Transgenic | 1 | 2021 | 1947 | 0.130 |
Why?
| | Lung Injury | 1 | 2018 | 192 | 0.130 |
Why?
| | Mice, Knockout | 2 | 2021 | 2563 | 0.120 |
Why?
| | Methanol | 1 | 2015 | 29 | 0.120 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 130 | 0.120 |
Why?
| | Hyperammonemia | 1 | 2015 | 15 | 0.120 |
Why?
| | Inflammation Mediators | 2 | 2015 | 475 | 0.120 |
Why?
| | Pneumonia, Bacterial | 1 | 2013 | 103 | 0.100 |
Why?
| | Serum Albumin, Bovine | 1 | 2012 | 60 | 0.100 |
Why?
| | Respiration, Artificial | 1 | 2016 | 528 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2018 | 830 | 0.100 |
Why?
| | Ketoglutaric Acids | 1 | 2011 | 15 | 0.100 |
Why?
| | Muscular Dystrophies | 1 | 2011 | 36 | 0.090 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2011 | 38 | 0.090 |
Why?
| | Pseudomonas aeruginosa | 1 | 2013 | 298 | 0.090 |
Why?
| | Transfection | 1 | 2013 | 863 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2021 | 5038 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1736 | 0.090 |
Why?
| | Cell Line | 3 | 2011 | 2629 | 0.090 |
Why?
| | Respiratory Mucosa | 1 | 2012 | 251 | 0.090 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2009 | 43 | 0.080 |
Why?
| | Neutrophils | 1 | 2013 | 1089 | 0.080 |
Why?
| | Lysosomes | 1 | 2009 | 123 | 0.080 |
Why?
| | Smith-Lemli-Opitz Syndrome | 1 | 2007 | 17 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2018 | 3861 | 0.070 |
Why?
| | Simvastatin | 1 | 2007 | 58 | 0.070 |
Why?
| | Cell Membrane Permeability | 2 | 2018 | 83 | 0.060 |
Why?
| | Cell Membrane | 3 | 2017 | 670 | 0.060 |
Why?
| | Cholesterol | 1 | 2007 | 368 | 0.060 |
Why?
| | Lung Diseases | 1 | 2011 | 690 | 0.060 |
Why?
| | Receptors, Glycine | 1 | 2004 | 4 | 0.060 |
Why?
| | Myoclonus | 1 | 2004 | 13 | 0.060 |
Why?
| | Female | 6 | 2021 | 59328 | 0.050 |
Why?
| | Thermodynamics | 1 | 2004 | 380 | 0.050 |
Why?
| | Protein Kinase C | 2 | 2017 | 271 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2021 | 48 | 0.050 |
Why?
| | Superoxide Dismutase | 1 | 2023 | 305 | 0.050 |
Why?
| | Computer Simulation | 1 | 2004 | 873 | 0.040 |
Why?
| | Neovascularization, Physiologic | 1 | 2021 | 174 | 0.040 |
Why?
| | Models, Molecular | 1 | 2004 | 1368 | 0.040 |
Why?
| | Rats | 3 | 2013 | 4913 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2023 | 385 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 2022 | 356 | 0.040 |
Why?
| | Male | 4 | 2018 | 55400 | 0.040 |
Why?
| | Phosphorylation | 2 | 2016 | 1558 | 0.040 |
Why?
| | Pilot Projects | 1 | 2022 | 1360 | 0.040 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2018 | 110 | 0.040 |
Why?
| | Critical Illness | 1 | 2022 | 640 | 0.040 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2017 | 56 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 4883 | 0.030 |
Why?
| | Lipoproteins, LDL | 1 | 2017 | 127 | 0.030 |
Why?
| | Bleomycin | 1 | 2018 | 228 | 0.030 |
Why?
| | Proteolysis | 1 | 2017 | 142 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2017 | 89 | 0.030 |
Why?
| | Hydroxylation | 1 | 2016 | 28 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 391 | 0.030 |
Why?
| | Epithelial Cells | 2 | 2012 | 946 | 0.030 |
Why?
| | Renal Replacement Therapy | 1 | 2015 | 66 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 594 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2015 | 151 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 281 | 0.030 |
Why?
| | Acidosis, Respiratory | 1 | 2013 | 3 | 0.030 |
Why?
| | HL-60 Cells | 1 | 2013 | 28 | 0.030 |
Why?
| | Nuclear Envelope | 1 | 2013 | 21 | 0.030 |
Why?
| | Bacterial Load | 1 | 2013 | 58 | 0.030 |
Why?
| | Electroporation | 1 | 2013 | 31 | 0.030 |
Why?
| | Solutions | 1 | 2013 | 144 | 0.030 |
Why?
| | Electric Impedance | 1 | 2013 | 100 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2013 | 148 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 278 | 0.030 |
Why?
| | Plasmids | 1 | 2013 | 343 | 0.030 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2015 | 241 | 0.030 |
Why?
| | Biomarkers | 1 | 2022 | 3397 | 0.030 |
Why?
| | Phagocytosis | 1 | 2013 | 349 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 534 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 6195 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 522 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1331 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 733 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1144 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1003 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1014 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2013 | 673 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2322 | 0.020 |
Why?
| | Suicide | 1 | 2015 | 508 | 0.020 |
Why?
| | Half-Life | 1 | 2009 | 141 | 0.020 |
Why?
| | Ubiquitination | 1 | 2009 | 86 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1128 | 0.020 |
Why?
| | Child | 2 | 2022 | 18404 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2182 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2009 | 370 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9115 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2700 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2009 | 613 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 2007 | 157 | 0.020 |
Why?
| | Kinetics | 1 | 2009 | 1547 | 0.020 |
Why?
| | Helix-Turn-Helix Motifs | 1 | 2004 | 3 | 0.010 |
Why?
| | Stiff-Person Syndrome | 1 | 2004 | 7 | 0.010 |
Why?
| | Reflex, Startle | 1 | 2004 | 57 | 0.010 |
Why?
| | Patch-Clamp Techniques | 1 | 2004 | 239 | 0.010 |
Why?
| | Glycine | 1 | 2004 | 152 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2004 | 345 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 200 | 0.010 |
Why?
| | Neural Inhibition | 1 | 2004 | 139 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2007 | 459 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 6077 | 0.010 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 373 | 0.010 |
Why?
| | Genotype | 1 | 2007 | 1757 | 0.010 |
Why?
| | Protein Conformation | 1 | 2004 | 803 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 1837 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 17802 | 0.010 |
Why?
|
|
Vohwinkel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|